Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 229 entries
Sorted by: Best Match Show Resources per page
Low Molecular Weight Norbornadiene Derivatives for Molecular Solar-Thermal Energy Storage.

Chemistry (Weinheim an der Bergstrasse, Germany)

Quant M, Lennartson A, Dreos A, Kuisma M, Erhart P, Börjesson K, Moth-Poulsen K.
PMID: 27492997
Chemistry. 2016 Sep 05;22(37):13265-74. doi: 10.1002/chem.201602530. Epub 2016 Aug 05.

Molecular solar-thermal energy storage systems are based on molecular switches that reversibly convert solar energy into chemical energy. Herein, we report the synthesis, characterization, and computational evaluation of a series of low molecular weight (193-260 g mol(-1) ) norbornadiene-quadricyclane...

Cite
Quant M, Lennartson A, Dreos A, et al. Low Molecular Weight Norbornadiene Derivatives for Molecular Solar-Thermal Energy Storage. Chemistry. 2016;22(37):13265-74doi: 10.1002/chem.201602530.
Quant, M., Lennartson, A., Dreos, A., Kuisma, M., Erhart, P., Börjesson, K., & Moth-Poulsen, K. (2016). Low Molecular Weight Norbornadiene Derivatives for Molecular Solar-Thermal Energy Storage. Chemistry (Weinheim an der Bergstrasse, Germany), 22(37), 13265-74. https://doi.org/10.1002/chem.201602530
Quant, Maria, et al. "Low Molecular Weight Norbornadiene Derivatives for Molecular Solar-Thermal Energy Storage." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 22,37 (2016): 13265-74. doi: https://doi.org/10.1002/chem.201602530
Quant M, Lennartson A, Dreos A, Kuisma M, Erhart P, Börjesson K, Moth-Poulsen K. Low Molecular Weight Norbornadiene Derivatives for Molecular Solar-Thermal Energy Storage. Chemistry. 2016 Sep 05;22(37):13265-74. doi: 10.1002/chem.201602530. Epub 2016 Aug 05. PMID: 27492997; PMCID: PMC5096010.
Copy Download .nbib Format: NLM
Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk.

Nature genetics

Warren HR, Evangelou E, Cabrera CP, Gao H, Ren M, Mifsud B, Ntalla I, Surendran P, Liu C, Cook JP, Kraja AT, Drenos F, Loh M, Verweij N, Marten J, Karaman I, Segura Lepe MP, O'Reilly PF, Knight J, Snieder H, Kato N, He J, Tai ES, Said MA, Porteous D, Alver M, Poulter N, Farrall M, Gansevoort RT, Padmanabhan S, Mägi R, Stanton A, Connell J, Bakker SJL, Metspalu A, Shields DC, Thom S, Brown M, Sever P, Esko T, Hayward C, van der Harst P, Saleheen D, Chowdhury R, Chambers JC, Chasman DI, Chakravarti A, Newton-Cheh C, Lindgren CM, Levy D, Kooner JS, Keavney B, Tomaszewski M, Samani NJ, Howson JMM, Tobin MD, Munroe PB, Ehret GB, Wain LV, Barnes MR, Tzoulaki I, Caulfield MJ, Elliott P.
PMID: 28951623
Nat Genet. 2017 Sep 27;49(10):1558. doi: 10.1038/ng1017-1558a.

No abstract available.

Cite
Warren HR, Evangelou E, Cabrera CP, et al. Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet. 2017;49(10):1558doi: 10.1038/ng1017-1558a.
Warren, H. R., Evangelou, E., Cabrera, C. P., Gao, H., Ren, M., Mifsud, B., Ntalla, I., Surendran, P., Liu, C., Cook, J. P., Kraja, A. T., Drenos, F., Loh, M., Verweij, N., Marten, J., Karaman, I., Segura Lepe, M. P., O'Reilly, P. F., Knight, J., Snieder, H., Kato, N., He, J., Tai, E. S., Said, M. A., Porteous, D., Alver, M., Poulter, N., Farrall, M., Gansevoort, R. T., Padmanabhan, S., Mägi, R., Stanton, A., Connell, J., Bakker, S. J. L., Metspalu, A., Shields, D. C., Thom, S., Brown, M., Sever, P., Esko, T., Hayward, C., van der Harst, P., Saleheen, D., Chowdhury, R., Chambers, J. C., Chasman, D. I., Chakravarti, A., Newton-Cheh, C., Lindgren, C. M., Levy, D., Kooner, J. S., Keavney, B., Tomaszewski, M., Samani, N. J., Howson, J. M. M., Tobin, M. D., Munroe, P. B., Ehret, G. B., Wain, L. V., Barnes, M. R., Tzoulaki, I., Caulfield, M. J., Elliott, P. (2017). Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nature genetics, 49(10), 1558. https://doi.org/10.1038/ng1017-1558a
Warren, Helen R, et al. "Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk." Nature genetics vol. 49,10 (2017): 1558. doi: https://doi.org/10.1038/ng1017-1558a
Warren HR, Evangelou E, Cabrera CP, Gao H, Ren M, Mifsud B, Ntalla I, Surendran P, Liu C, Cook JP, Kraja AT, Drenos F, Loh M, Verweij N, Marten J, Karaman I, Segura Lepe MP, O'Reilly PF, Knight J, Snieder H, Kato N, He J, Tai ES, Said MA, Porteous D, Alver M, Poulter N, Farrall M, Gansevoort RT, Padmanabhan S, Mägi R, Stanton A, Connell J, Bakker SJL, Metspalu A, Shields DC, Thom S, Brown M, Sever P, Esko T, Hayward C, van der Harst P, Saleheen D, Chowdhury R, Chambers JC, Chasman DI, Chakravarti A, Newton-Cheh C, Lindgren CM, Levy D, Kooner JS, Keavney B, Tomaszewski M, Samani NJ, Howson JMM, Tobin MD, Munroe PB, Ehret GB, Wain LV, Barnes MR, Tzoulaki I, Caulfield MJ, Elliott P. Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet. 2017 Sep 27;49(10):1558. doi: 10.1038/ng1017-1558a. PMID: 28951623.
Copy Download .nbib Format: NLM
A guest-induced assembly of a molecular box from methylcobaloxime and 1, 4-phenylenebisboronic acid.

Inorganic chemistry

Dreos R, Nardin G, Randaccio L, Siega P, Tauzher G.
PMID: 12693246
Inorg Chem. 2003 Jan 27;42(2):612-7. doi: 10.1021/ic025909s.

The guest-induced synthesis of a molecular box from methylaquacobaloxime and 1,4-phenylenebisboronic acid, with pyrazine (pz) as guest, is described. The resulting supramolecular species was characterized by X-ray structural analysis, 1H and 13C NMR spectroscopy, and low-resolution electrospray ionization (ES)...

Cite
Dreos R, Nardin G, Randaccio L, et al. A guest-induced assembly of a molecular box from methylcobaloxime and 1, 4-phenylenebisboronic acid. Inorg Chem. 2003;42(2):612-7doi: 10.1021/ic025909s.
Dreos, R., Nardin, G., Randaccio, L., Siega, P., & Tauzher, G. (2003). A guest-induced assembly of a molecular box from methylcobaloxime and 1, 4-phenylenebisboronic acid. Inorganic chemistry, 42(2), 612-7. https://doi.org/10.1021/ic025909s
Dreos, Renata, et al. "A guest-induced assembly of a molecular box from methylcobaloxime and 1, 4-phenylenebisboronic acid." Inorganic chemistry vol. 42,2 (2003): 612-7. doi: https://doi.org/10.1021/ic025909s
Dreos R, Nardin G, Randaccio L, Siega P, Tauzher G. A guest-induced assembly of a molecular box from methylcobaloxime and 1, 4-phenylenebisboronic acid. Inorg Chem. 2003 Jan 27;42(2):612-7. doi: 10.1021/ic025909s. PMID: 12693246.
Copy Download .nbib Format: NLM
A molecular box derived from cobaloxime units held together by 4-pyridinylboronic acid residues.

Inorganic chemistry

Dreos R, Nardin G, Randaccio L, Siega P, Tauzher G, Vrdoljak V.
PMID: 11599951
Inorg Chem. 2001 Oct 22;40(22):5536-40. doi: 10.1021/ic0102034.

The reaction of CH(3)Co(DH)(2)H(2)O with 4-pyridinyl boronic acid in methanol or water affords the dinuclear complexes [MeCo(DH)(DB(OR)(4-Py))](2), with R = Me (2) or H (3), respectively, through reaction of boron with the oxime oxygens of the alkylcobaloxime and coordination...

Cite
Dreos R, Nardin G, Randaccio L, et al. A molecular box derived from cobaloxime units held together by 4-pyridinylboronic acid residues. Inorg Chem. 2001;40(22):5536-40doi: 10.1021/ic0102034.
Dreos, R., Nardin, G., Randaccio, L., Siega, P., Tauzher, G., & Vrdoljak, V. (2001). A molecular box derived from cobaloxime units held together by 4-pyridinylboronic acid residues. Inorganic chemistry, 40(22), 5536-40. https://doi.org/10.1021/ic0102034
Dreos, R, et al. "A molecular box derived from cobaloxime units held together by 4-pyridinylboronic acid residues." Inorganic chemistry vol. 40,22 (2001): 5536-40. doi: https://doi.org/10.1021/ic0102034
Dreos R, Nardin G, Randaccio L, Siega P, Tauzher G, Vrdoljak V. A molecular box derived from cobaloxime units held together by 4-pyridinylboronic acid residues. Inorg Chem. 2001 Oct 22;40(22):5536-40. doi: 10.1021/ic0102034. PMID: 11599951.
Copy Download .nbib Format: NLM
New beta cis folded organocobalt derivatives with a salen-type ligand.

Inorganic chemistry

Dreos R, Nardin G, Randaccio L, Siega P, Tauzher G, Vrdoljak V.
PMID: 14552633
Inorg Chem. 2003 Oct 20;42(21):6805-11. doi: 10.1021/ic034085r.

The reduction of [Co(III)(tmsalen)py(2)](+)ClO(4)(-), where tmsalen = 4,4',7,7'-tetramethylsalen, with NaBH(4)/PdCl(2) in alkaline methanolic solution, followed by the oxidative addition of CH(2)ClI, leads to the expected trans organometallic dimeric species 1, [CH(2)ClCo(tmsalen)](2), provided that the product is recovered from the...

Cite
Dreos R, Nardin G, Randaccio L, et al. New beta cis folded organocobalt derivatives with a salen-type ligand. Inorg Chem. 2003;42(21):6805-11doi: 10.1021/ic034085r.
Dreos, R., Nardin, G., Randaccio, L., Siega, P., Tauzher, G., & Vrdoljak, V. (2003). New beta cis folded organocobalt derivatives with a salen-type ligand. Inorganic chemistry, 42(21), 6805-11. https://doi.org/10.1021/ic034085r
Dreos, Renata, et al. "New beta cis folded organocobalt derivatives with a salen-type ligand." Inorganic chemistry vol. 42,21 (2003): 6805-11. doi: https://doi.org/10.1021/ic034085r
Dreos R, Nardin G, Randaccio L, Siega P, Tauzher G, Vrdoljak V. New beta cis folded organocobalt derivatives with a salen-type ligand. Inorg Chem. 2003 Oct 20;42(21):6805-11. doi: 10.1021/ic034085r. PMID: 14552633.
Copy Download .nbib Format: NLM
Radical-polar crossover domino reactions involving organozinc and mixed organocopper/organozinc reagents.

Chemistry (Weinheim an der Bergstrasse, Germany)

Denes F, Cutri S, Perez-Luna A, Chemla F.
PMID: 16789032
Chemistry. 2006 Aug 25;12(25):6506-13. doi: 10.1002/chem.200600334.

A domino process involving Michael addition and carbocyclization has been developed starting from beta-N-allylamino enoates and various organometallic reagents (organozinc halides, diorganozinc reagents, and copper/zinc mixed species). In all cases the mechanism of this domino reaction has been evidenced...

Cite
Denes F, Cutri S, Perez-Luna A, et al. Radical-polar crossover domino reactions involving organozinc and mixed organocopper/organozinc reagents. Chemistry. 2006;12(25):6506-13doi: 10.1002/chem.200600334.
Denes, F., Cutri, S., Perez-Luna, A., & Chemla, F. (2006). Radical-polar crossover domino reactions involving organozinc and mixed organocopper/organozinc reagents. Chemistry (Weinheim an der Bergstrasse, Germany), 12(25), 6506-13. https://doi.org/10.1002/chem.200600334
Denes, Fabrice, et al. "Radical-polar crossover domino reactions involving organozinc and mixed organocopper/organozinc reagents." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 12,25 (2006): 6506-13. doi: https://doi.org/10.1002/chem.200600334
Denes F, Cutri S, Perez-Luna A, Chemla F. Radical-polar crossover domino reactions involving organozinc and mixed organocopper/organozinc reagents. Chemistry. 2006 Aug 25;12(25):6506-13. doi: 10.1002/chem.200600334. PMID: 16789032.
Copy Download .nbib Format: NLM
Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke.

Biomarker insights

Allard L, Turck N, Burkhard PR, Walter N, Rosell A, Gex-Fabry M, Hochstrasser DF, Montaner J, Sanchez JC.
PMID: 19662200
Biomark Insights. 2007 Apr 19;2:155-64.

BACKGROUND: Efficacy of thrombolysis in acute ischemic stroke is strongly related to physician's ability to make an accurate diagnosis and to intervene within 3-6 h after event onset. In this context, the discovery and validation of very early blood...

Cite
Allard L, Turck N, Burkhard PR, et al. Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke. Biomark Insights. 2007;2:155-64
Allard, L., Turck, N., Burkhard, P. R., Walter, N., Rosell, A., Gex-Fabry, M., Hochstrasser, D. F., Montaner, J., & Sanchez, J. C. (2007). Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke. Biomarker insights, 2155-64.
Allard, Laure, et al. "Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke." Biomarker insights vol. 2 (2007): 155-64.
Allard L, Turck N, Burkhard PR, Walter N, Rosell A, Gex-Fabry M, Hochstrasser DF, Montaner J, Sanchez JC. Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke. Biomark Insights. 2007 Apr 19;2:155-64. PMID: 19662200; PMCID: PMC2717829.
Copy Download .nbib Format: NLM
Impact of preanalytical variables on the analysis of biological fluids in proteomic studies.

Proteomics. Clinical applications

Ferguson RE, Hochstrasser DF, Banks RE.
PMID: 21136730
Proteomics Clin Appl. 2007 Aug;1(8):739-46. doi: 10.1002/prca.200700380. Epub 2007 Jul 10.

Although proteomic technologies have been enthusiastically embraced in the field of biomarker discovery and particularly with biological fluids, it is increasingly being recognized that pre-analytical effects, i.e. those occurring prior to the point of actual sample analysis and including...

Cite
Ferguson RE, Hochstrasser DF, Banks RE. Impact of preanalytical variables on the analysis of biological fluids in proteomic studies. Proteomics Clin Appl. 2007;1(8):739-46doi: 10.1002/prca.200700380.
Ferguson, R. E., Hochstrasser, D. F., & Banks, R. E. (2007). Impact of preanalytical variables on the analysis of biological fluids in proteomic studies. Proteomics. Clinical applications, 1(8), 739-46. https://doi.org/10.1002/prca.200700380
Ferguson, Roisean E, et al. "Impact of preanalytical variables on the analysis of biological fluids in proteomic studies." Proteomics. Clinical applications vol. 1,8 (2007): 739-46. doi: https://doi.org/10.1002/prca.200700380
Ferguson RE, Hochstrasser DF, Banks RE. Impact of preanalytical variables on the analysis of biological fluids in proteomic studies. Proteomics Clin Appl. 2007 Aug;1(8):739-46. doi: 10.1002/prca.200700380. Epub 2007 Jul 10. PMID: 21136730.
Copy Download .nbib Format: NLM
Proteomic analysis of a podocyte vesicle-enriched fraction from human normal and pathological urine samples.

Proteomics. Clinical applications

Lescuyer P, Pernin A, Hainard A, Bigeire C, Burgess JA, Zimmermann-Ivol C, Sanchez JC, Schifferli JA, Hochstrasser DF, Moll S.
PMID: 21136901
Proteomics Clin Appl. 2008 Jul;2(7):1008-18. doi: 10.1002/prca.200800033. Epub 2008 Jul 10.

Podocytes (glomerular visceral epithelial cells) release vesicles into urine. Podocyte vesicle-enriched fractions from normal and pathological human urine samples were prepared for proteomic analysis. An immunoadsorption method was applied and enrichment of podocyte vesicles was assessed. We identified 76...

Cite
Lescuyer P, Pernin A, Hainard A, et al. Proteomic analysis of a podocyte vesicle-enriched fraction from human normal and pathological urine samples. Proteomics Clin Appl. 2008;2(7):1008-18doi: 10.1002/prca.200800033.
Lescuyer, P., Pernin, A., Hainard, A., Bigeire, C., Burgess, J. A., Zimmermann-Ivol, C., Sanchez, J. C., Schifferli, J. A., Hochstrasser, D. F., & Moll, S. (2008). Proteomic analysis of a podocyte vesicle-enriched fraction from human normal and pathological urine samples. Proteomics. Clinical applications, 2(7), 1008-18. https://doi.org/10.1002/prca.200800033
Lescuyer, Pierre, et al. "Proteomic analysis of a podocyte vesicle-enriched fraction from human normal and pathological urine samples." Proteomics. Clinical applications vol. 2,7 (2008): 1008-18. doi: https://doi.org/10.1002/prca.200800033
Lescuyer P, Pernin A, Hainard A, Bigeire C, Burgess JA, Zimmermann-Ivol C, Sanchez JC, Schifferli JA, Hochstrasser DF, Moll S. Proteomic analysis of a podocyte vesicle-enriched fraction from human normal and pathological urine samples. Proteomics Clin Appl. 2008 Jul;2(7):1008-18. doi: 10.1002/prca.200800033. Epub 2008 Jul 10. PMID: 21136901.
Copy Download .nbib Format: NLM
Analysis of proteomes using the molecular scanner.

CSH protocols

Déon C, Bienvenut W, Sanchez JC, Hochstrasser DF, Müller M, Gras R, Appel RD.
PMID: 21357015
CSH Protoc. 2007 Feb 01;2007:pdb.prot4592. doi: 10.1101/pdb.prot4592.

INTRODUCTIONThe molecular scanner offers a flexible and powerful visualization tool that can create a fully annotated 2D gel electrophoresis map. Proteins separated by 2D gel electrophoresis are simultaneously digested while undergoing electrotransfer from the gel to a membrane. The...

Cite
Déon C, Bienvenut W, Sanchez JC, et al. Analysis of proteomes using the molecular scanner. CSH Protoc. 2007;2007:pdb.prot4592doi: 10.1101/pdb.prot4592.
Déon, C., Bienvenut, W., Sanchez, J. C., Hochstrasser, D. F., Müller, M., Gras, R., & Appel, R. D. (2007). Analysis of proteomes using the molecular scanner. CSH protocols, 2007pdb.prot4592. https://doi.org/10.1101/pdb.prot4592
Déon, Catherine, et al. "Analysis of proteomes using the molecular scanner." CSH protocols vol. 2007 (2007): pdb.prot4592. doi: https://doi.org/10.1101/pdb.prot4592
Déon C, Bienvenut W, Sanchez JC, Hochstrasser DF, Müller M, Gras R, Appel RD. Analysis of proteomes using the molecular scanner. CSH Protoc. 2007 Feb 01;2007:pdb.prot4592. doi: 10.1101/pdb.prot4592. PMID: 21357015.
Copy Download .nbib Format: NLM
Discovery of Novel Allosteric HCV NS5B Inhibitors. 2. Lactam-Containing Thiophene Carboxylates.

ACS medicinal chemistry letters

Li P, Dorsch W, Lauffer DJ, Bilimoria D, Chauret N, Court JJ, Das SK, Denis F, Mani N, Nanthakumar S, Nicolas O, Rao BG, Ronkin S, Selliah S, Shawgo RS, Stearns R, Tang Q, Waal ND, Green J.
PMID: 28197321
ACS Med Chem Lett. 2017 Jan 31;8(2):251-255. doi: 10.1021/acsmedchemlett.6b00479. eCollection 2017 Feb 09.

Lomibuvir (

Cite
Li P, Dorsch W, Lauffer DJ, et al. Discovery of Novel Allosteric HCV NS5B Inhibitors. 2. Lactam-Containing Thiophene Carboxylates. ACS Med Chem Lett. 2017;8(2):251-255doi: 10.1021/acsmedchemlett.6b00479.
Li, P., Dorsch, W., Lauffer, D. J., Bilimoria, D., Chauret, N., Court, J. J., Das, S. K., Denis, F., Mani, N., Nanthakumar, S., Nicolas, O., Rao, B. G., Ronkin, S., Selliah, S., Shawgo, R. S., Stearns, R., Tang, Q., Waal, N. D., & Green, J. (2017). Discovery of Novel Allosteric HCV NS5B Inhibitors. 2. Lactam-Containing Thiophene Carboxylates. ACS medicinal chemistry letters, 8(2), 251-255. https://doi.org/10.1021/acsmedchemlett.6b00479
Li, Pan, et al. "Discovery of Novel Allosteric HCV NS5B Inhibitors. 2. Lactam-Containing Thiophene Carboxylates." ACS medicinal chemistry letters vol. 8,2 (2017): 251-255. doi: https://doi.org/10.1021/acsmedchemlett.6b00479
Li P, Dorsch W, Lauffer DJ, Bilimoria D, Chauret N, Court JJ, Das SK, Denis F, Mani N, Nanthakumar S, Nicolas O, Rao BG, Ronkin S, Selliah S, Shawgo RS, Stearns R, Tang Q, Waal ND, Green J. Discovery of Novel Allosteric HCV NS5B Inhibitors. 2. Lactam-Containing Thiophene Carboxylates. ACS Med Chem Lett. 2017 Jan 31;8(2):251-255. doi: 10.1021/acsmedchemlett.6b00479. eCollection 2017 Feb 09. PMID: 28197321; PMCID: PMC5304295.
Copy Download .nbib Format: NLM
[In process].

Pflege Zeitschrift

Arens F.
PMID: 29425437
Pflege Z. 2017 Apr;70(4):44-7.

No abstract available.

Cite
Arens F. [In process]. Pflege Z. 2017;70(4):44-7
Arens, F. (2017). [In process]. Pflege Zeitschrift, 70(4), 44-7.
Arens, Frank. "[In process]." Pflege Zeitschrift vol. 70,4 (2017): 44-7.
Arens F. [In process]. Pflege Z. 2017 Apr;70(4):44-7. German. PMID: 29425437.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 229 entries